Please login to the form below

Not currently logged in
Email:
Password:

Novacyt strengthens group with senior hire

Paul Eros joins as commercial director

Clinical diagnostics specialist Novacyt has appointed Paul Eros as its commercial director of Primerdesign, a role that will see him focus on building its business-to-business pipeline.

Following 30 years’ experience within the field of molecular diagnostics, including strategic global marketing, sales and product management, Eros joins the French group from DiaSorin, where he was vice president of molecular marketing.

Graham Mullis, Group CEO at Novacyt, said: “Paul’s considerable blue-chip commercial expertise specifically in molecular diagnostics will be hugely beneficial as we aim to convert our healthy pipeline of clinical projects and B2B opportunities into new contracts.

“I am confident that we have invested in a strong senior leadership team that can continue to drive growth from the many opportunities that we see.”

Eros completes Novacyt’s investment in its senior commercial leadership team, building on the earlier appointments of Ruth Powell as managing director of the NovaPrep division and Phil Sefton as managing director of LAB21 Products.

11th October 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics